No photo of Janice Mehnert

View Scopus Profile

Janice Mehnert

  • 1690 Citations
  • 22 h-Index
20022020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Janice Mehnert is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Safety Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Autophagy Medicine & Life Sciences
Riluzole Medicine & Life Sciences
Ligands Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2020

Wisconsin And New Jersey Alliance In Precision Experimental Therapeutics

Mehnert, J.

National Institutes of Health (NIH)

3/19/14 → 2/28/20

Project: Research project

Neoplasms
Clinical Trials
Therapeutics
Systems Biology
Pharmacogenetics

Research Output 2002 2019

A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors

Stein, M., Goodin, S., Gounder, M., Gibbon, D., Moss, R., Portal, D., Lindquist, D., Zhao, Y., Takebe, N., Tan, A., Aisner, J., Lin, H., Ready, N. & Mehnert, J., Jan 1 2019, (Accepted/In press) In : Investigational New Drugs.

Research output: Contribution to journal › Article

Carboplatin
Paclitaxel
Neoplasms
Area Under Curve
Prostate

A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors

Mehnert, J., Kaveney, A. D., Malhotra, J., Spencer, K., Portal, D., Goodin, S., Tan, A. R., Aisner, J., Moss, R. A., Lin, H., Bertino, J., Gibbon, D., Doyle, L. A., White, E. & Stein, M., Jan 1 2019, (Accepted/In press) In : Cancer chemotherapy and pharmacology.

Research output: Contribution to journal › Article

Hydroxychloroquine
Tumors
Neoplasms
Exanthema
Fatigue
3 Citations (Scopus)

Avelumab in patients with previously treated metastatic melanoma: Phase 1b results from the JAVELIN Solid Tumor trial

Keilholz, U., Mehnert, J., Bauer, S., Bourgeois, H., Patel, M. R., Gravenor, D., Nemunaitis, J. J., Taylor, M. H., Wyrwicz, L., Lee, K. W., Kasturi, V., Chin, K., Von Heydebreck, A. & Gulley, J. L., Jan 16 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 12.

Research output: Contribution to journal › Article

Melanoma
Neoplasms
Therapeutics
Disease-Free Survival
Survival
1 Citation (Scopus)

Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanoma

Andtbacka, R. H. I., Amatruda, T., Nemunaitis, J., Zager, J. S., Walker, J., Chesney, J. A., Liu, K., Hsu, C. P., Pickett, C. A. & Mehnert, J., Jan 1 2019, (Accepted/In press) In : EBioMedicine.

Research output: Contribution to journal › Article

Open Access
Oncolytic Viruses
Viruses
Melanoma
Occlusive Dressings
Blood

Clinical characterization of colitis arising from anti-PD-1 based therapy

Wang, D. Y., Mooradian, M. J., Kim, D. W., Shah, N. J., Fenton, S. E., Conry, R. M., Mehta, R., Silk, A., Zhou, A., Compton, M. L., Al-Rohil, R. N., Lee, S., Voorhees, A. L., Ha, L., McKee, S., Norrell, J. T., Mehnert, J., Puzanov, I., Sosman, J. A., Chandra, S. & 5 others, Gibney, G. T., Rapisuwon, S., Eroglu, Z., Sullivan, R. & Johnson, D. B., Jan 2 2019, In : OncoImmunology. 8, 1, e1524695.

Research output: Contribution to journal › Article

Colitis
Steroids
Therapeutics
Prednisone
Melanoma